AGO-OVAR 2.29

Trial Description: 
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Recurrent Ovarian
Trial Status: 
Recruiting
Contact person: